Literature DB >> 34151805

Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk.

Alina Solomon1,2, Ron Handels3,4, Anders Wimo4, Riitta Antikainen5,6,7, Tiina Laatikainen8,9,10, Esko Levälahti8, Markku Peltonen8, Hilkka Soininen1,11, Timo Strandberg5,12, Jaakko Tuomilehto8,13,14, Miia Kivipelto1,2,9,15, Tiia Ngandu2,8.   

Abstract

We investigated the effect of a multidomain lifestyle intervention on the risk of dementia estimated using the validated CAIDE risk score (post-hoc analysis). The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) is a 2-year randomized controlled trial among 1,260 at-risk older adults (60-77 years). Difference in the estimated mean change in CAIDE score at 2 years in the intervention compared to the control group was -0.16 (95 %CI -0.31 to 0.00) (p = 0.013), corresponding to a relative dementia risk reduction between 6.04-6.50%. This could be interpreted as a reflection of the prevention potential of the intervention.

Entities:  

Keywords:  Clinical trial; dementia; dementia risk score; lifestyle intervention; prevention

Year:  2021        PMID: 34151805     DOI: 10.3233/JAD-210331

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  2 in total

1.  Lifestyle modification and cognitive function among individuals with resistant hypertension: cognitive outcomes from the TRIUMPH trial.

Authors:  Patrick J Smith; Andrew Sherwood; Alan L Hinderliter; Stephanie Mabe; Lana L Watkins; Linda Craighead; Krista Ingle; Crystal Tyson; Forgive Avorgbedor; Pao-Hwa Lin; William E Kraus; Lawrence Liao; James A Blumenthal
Journal:  J Hypertens       Date:  2022-06-10       Impact factor: 4.776

Review 2.  Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines.

Authors:  Kaarin J Anstey; Lidan Zheng; Ruth Peters; Scherazad Kootar; Mariagnese Barbera; Ruth Stephen; Tarun Dua; Neerja Chowdhary; Alina Solomon; Miia Kivipelto
Journal:  Front Neurol       Date:  2022-01-04       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.